Page last updated: 2024-08-21

d-alpha tocopherol and Fra(X) Syndrome

d-alpha tocopherol has been researched along with Fra(X) Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caballero-Andaluz, R; Calvo-Medina, R; de Diego-Otero, Y; del Arco-Herrera, I; Fernández-Carvajal, I; Ferrando-Lucas, T; García-Guirado, F; Pérez-Costillas, L; Quintero-Navarro, C; Sánchez-Salido, L	1
de Diego-Otero, Y; Decara, J; del Arco-Herrera, I; el Bekay, R; Rodriguez-de Fonseca, F; Romero-Zerbo, Y; Sanchez, L	1
Au, J; Berry-Kravis, E; Hagerman, R; Lauterborn, J	1

Reviews

1 review(s) available for d-alpha tocopherol and Fra(X) Syndrome

Article	Year
Fragile X syndrome and targeted treatment trials. Results and problems in cell differentiation, 2012, Volume: 54 Topics: Animals; Anti-Bacterial Agents; Antioxidants; Baclofen; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Clinical Trials as Topic; Dendritic Spines; Donepezil; Dopamine; Enzyme Inhibitors; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Indans; Lithium Compounds; Melatonin; Mice; Mice, Knockout; Minocycline; Nootropic Agents; Piperidines; Receptor, Metabotropic Glutamate 5; Receptors, GABA; Receptors, Metabotropic Glutamate; Signal Transduction; Vitamin E	2012

Article

Year

Fragile X syndrome and targeted treatment trials.

Results and problems in cell differentiation, 2012, Volume: 54

Topics: Animals; Anti-Bacterial Agents; Antioxidants; Baclofen; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Clinical Trials as Topic; Dendritic Spines; Donepezil; Dopamine; Enzyme Inhibitors; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Indans; Lithium Compounds; Melatonin; Mice; Mice, Knockout; Minocycline; Nootropic Agents; Piperidines; Receptor, Metabotropic Glutamate 5; Receptors, GABA; Receptors, Metabotropic Glutamate; Signal Transduction; Vitamin E

2012

Trials

1 trial(s) available for d-alpha tocopherol and Fra(X) Syndrome

Article	Year
A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trial. Trials, 2014, Sep-03, Volume: 15 Topics: Adolescent; Adolescent Behavior; Adolescent Development; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Biomarkers; Checklist; Child; Child Behavior; Child Development; Clinical Protocols; Cognition; Double-Blind Method; Drug Combinations; Fragile X Syndrome; Humans; Male; Pilot Projects; Research Design; Spain; Time Factors; Treatment Outcome; Wechsler Scales	2014

Article

Year

A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trial.

Trials, 2014, Sep-03, Volume: 15

Topics: Adolescent; Adolescent Behavior; Adolescent Development; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Biomarkers; Checklist; Child; Child Behavior; Child Development; Clinical Protocols; Cognition; Double-Blind Method; Drug Combinations; Fragile X Syndrome; Humans; Male; Pilot Projects; Research Design; Spain; Time Factors; Treatment Outcome; Wechsler Scales

2014

Other Studies

1 other study(ies) available for d-alpha tocopherol and Fra(X) Syndrome

Article	Year
Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:4 Topics: Acetylcysteine; Aging; alpha-Tocopherol; Animals; Antioxidants; Behavior, Animal; Conditioning, Psychological; Dose-Response Relationship, Drug; Enzyme Activation; Exploratory Behavior; Fear; Fragile X Mental Retardation Protein; Fragile X Syndrome; Free Radicals; In Vitro Techniques; Male; Mice; Mice, Knockout; Neuropeptides; Oxidative Stress; Phenotype; Protein Kinase C-alpha; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Stress, Psychological	2009

Article

Year

Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:4

Topics: Acetylcysteine; Aging; alpha-Tocopherol; Animals; Antioxidants; Behavior, Animal; Conditioning, Psychological; Dose-Response Relationship, Drug; Enzyme Activation; Exploratory Behavior; Fear; Fragile X Mental Retardation Protein; Fragile X Syndrome; Free Radicals; In Vitro Techniques; Male; Mice; Mice, Knockout; Neuropeptides; Oxidative Stress; Phenotype; Protein Kinase C-alpha; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Stress, Psychological

2009